<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Fraction-variant VMAT planning for patients with complex gynecological and head-and-neck cancer - Health AI Hub</title>
    <meta name="description" content="This paper introduces a novel fraction-variant VMAT planning approach where different optimal treatment plans are delivered in different fractions, optimized si">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Fraction-variant VMAT planning for patients with complex gynecological and head-and-neck cancer</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2510.26563v1" target="_blank">2510.26563v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-10-30
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Nathan Torelli, Madalyne Day, Jan Unkelbach
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> physics.med-ph
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2510.26563v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2510.26563v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a novel fraction-variant VMAT planning approach where different optimal treatment plans are delivered in different fractions, optimized simultaneously based on their cumulative physical dose. The study demonstrates that this method significantly improves dosimetric quality, achieving better target coverage and reduced organ-at-risk dose for complex gynecological and head-and-neck cancers. Crucially, it achieves this while also reducing per-fraction delivery times compared to conventional fraction-invariant VMAT, addressing patient discomfort and motion concerns.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is highly medically relevant as it offers a practical solution to enhance radiation therapy efficacy and patient experience. By improving dosimetric quality for complex tumors while simultaneously reducing per-fraction treatment times, it can lead to more precise treatments, less patient discomfort, and reduced risks associated with intra-fractional motion.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper describes the development of a 'direct aperture optimization algorithm' for VMAT planning. This algorithm simultaneously optimizes different VMAT plans for delivery in different fractions. Such computational optimization techniques are a direct application of AI/computational intelligence in medicine, specifically in medical imaging and treatment planning, enabling more precise, efficient, and personalized radiation therapy for cancer patients.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>VMAT plans with more arcs improve dosimetric quality but increase delivery time, leading to patient discomfort and intra-fractional motion.</li>
                    
                    <li>A direct aperture optimization (DAO) algorithm was developed to simultaneously optimize different VMAT plans for delivery in distinct fractions, based on cumulative physical dose.</li>
                    
                    <li>Each fractional VMAT plan is designed to deliver a uniform dose to the target, ensuring robust treatment against inter-fractional setup errors and maintaining the fractionation scheme.</li>
                    
                    <li>Evaluated in-silico on ten patients with complex gynecological and head-and-neck cancers.</li>
                    
                    <li>Fraction-variant treatments consistently achieved better target coverage and reduced dose to organs-at-risk compared to fraction-invariant treatments, with benefits increasing with the number of different fractional plans.</li>
                    
                    <li>1-arc and 2-arc fraction-variant treatments could approximate the dosimetric quality of 3-arc fraction-invariant treatments.</li>
                    
                    <li>Delivery times were significantly reduced: 1-arc fraction-variant (60 s), 2-arc fraction-variant (120 s) compared to 3-arc fraction-invariant (180 s).</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study involved the development of a novel direct aperture optimization (DAO) algorithm. This algorithm is designed to simultaneously optimize multiple distinct VMAT plans, each intended for delivery in a different fraction of a patient's overall treatment course. The optimization process is based on the cumulative physical dose delivered over all fractions. A key constraint ensures that each individual VMAT plan delivers a uniform dose within the target volume, thereby maintaining the intended fractionation scheme and enhancing robustness against inter-fractional setup errors. This fraction-variant VMAT approach was then evaluated in-silico using computed tomography data from ten patients diagnosed with complex gynecological and head-and-neck cancers.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>Fraction-variant VMAT treatments consistently achieved superior dosimetric quality across all evaluated patients, demonstrating improved target coverage and reduced dose to critical organs-at-risk when compared to conventional fraction-invariant treatments. The study found that the dosimetric benefit increased with the number of different plans delivered across fractions. Furthermore, 1-arc and 2-arc fraction-variant treatments were able to approximate the high dosimetric quality typically achieved by 3-arc fraction-invariant treatments, while significantly reducing the per-fraction delivery time from 180 seconds (for 3-arc fraction-invariant) to 60 seconds and 120 seconds, respectively.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research has significant potential to improve clinical radiation therapy by allowing for highly conformal and precise dose delivery to complex tumors, such as those found in gynecological and head-and-neck regions, while simultaneously shortening the treatment duration per fraction. Shorter treatment times can directly enhance patient comfort, reduce intra-fractional motion artifacts, and potentially increase the throughput capacity of radiotherapy clinics, leading to more efficient and safer treatment delivery.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The primary limitation explicitly stated within the abstract is that the evaluation of this novel approach was conducted "in-silico." This implies that the findings are based on computational simulations and require prospective clinical validation in a real-world setting to confirm their efficacy and safety in patients.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly state future research directions. However, logical next steps would likely include prospective clinical trials to validate the in-silico findings, further investigation into the optimal number and design of fraction-variant plans for different tumor sites and complexities, and exploring the integration of this planning approach with advanced adaptive radiotherapy techniques.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Radiation Oncology</span>
                    
                    <span class="tag">Medical Physics</span>
                    
                    <span class="tag">Gynecology Oncology</span>
                    
                    <span class="tag">Head and Neck Oncology</span>
                    
                    <span class="tag">Radiation Therapy Planning</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Volumetric Modulated Arc Therapy</span>
                    
                    <span class="tag tag-keyword">VMAT</span>
                    
                    <span class="tag tag-keyword">Fraction-variant</span>
                    
                    <span class="tag tag-keyword">Direct Aperture Optimization</span>
                    
                    <span class="tag tag-keyword">Dosimetric Quality</span>
                    
                    <span class="tag tag-keyword">Delivery Efficiency</span>
                    
                    <span class="tag tag-keyword">Gynecological Cancer</span>
                    
                    <span class="tag tag-keyword">Head-and-Neck Cancer</span>
                    
                    <span class="tag tag-keyword">Radiation Oncology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Background and Purpose: Increasing the number of arcs in volumetric modulated
arc therapy (VMAT) allows for better intensity modulation and may improve plan
quality. However, this leads to longer delivery times, which may cause patient
discomfort and increase intra-fractional motion. In this study, it was
investigated whether the delivery of different VMAT plans in different
fractions may improve the dosimetric quality and delivery efficiency for the
treatment of patients with complex tumor geometries.
  Materials and Methods: A direct aperture optimization algorithm was developed
which allows for the simultaneous optimization of different VMAT plans to be
delivered in different fractions, based on their cumulative physical dose. Each
VMAT plan is constrained to deliver a uniform dose within the target volume,
such that the entire treatment does not alter the fractionation scheme and is
robust against inter-fractional setup errors. This approach was evaluated
in-silico for ten patients with gynecological and head-and-neck cancer.
  Results: For all patients, fraction-variant treatments achieved better target
coverage and reduced the dose to critical organs-at-risk compared to
fraction-invariant treatments that deliver the same plan in every fraction,
where the dosimetric benefit was shown to increase with the number of different
plans to be delivered. In addition, 1-arc and 2-arc fraction-variant treatments
could approximate the dosimetric quality of 3-arc fraction-invariant
treatments, while reducing the delivery time from 180 s to 60 s and 120 s,
respectively.
  Conclusions: Fraction-variant VMAT treatments may achieve excellent
dosimetric quality for patients with complex tumor geometries, while keeping
the delivery time per fraction viable.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>